Biotechnology As we have throughout the COVID-19 pandemic, the US Food and Drug Administration has used the best available science as the virus has evolved to make informed decisions with the health and safety of the American public in mind. Ensuring that healthcare providers on the frontlines have the best tools available to treat patients is a top priority for the agency, according to a statement from Dr Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research. 25 January 2022